Pharmacokinetics of intravenous omeprazole in critically ill paediatric patients Maria Jose SolanaJesús López-Herce Review Article 30 December 2009 Pages: 323 - 330
Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact Zoltán KissSteven ElliottJános Szegedi Review Article 02 February 2010 Pages: 331 - 340
Unbalanced reporting of benefits and harms in abstracts on rofecoxib Anders W. JørgensenKarsten Juhl JørgensenPeter C. Gøtzsche Special Article 17 February 2010 Pages: 341 - 347
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients Filip JosephsonMaria C. H. AnderssonYlva Böttiger Clinical Trial 05 December 2009 Pages: 349 - 357
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria Antonia C. KastorisPetros I. RafailidisMatthew E. Falagas Pharmacodynamics 26 February 2010 Pages: 359 - 368
Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-example Alain Li-Wan-PoPeter FarndonMichael Griffiths Pharmacogenetics 29 January 2010 Pages: 369 - 374
Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting Annette HaberlManfred MoeschNils von Hentig Pharmacokinetics and Disposition 24 December 2009 Pages: 375 - 381
CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity Henrik GréenKarin SkoglundKourosh Lotfi Pharmacokinetics and Disposition 07 January 2010 Pages: 383 - 386
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone Teijo I. SaariJuha GrönlundKlaus T. Olkkola Pharmacokinetics and Disposition 14 January 2010 Pages: 387 - 397
Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study Øystein KarlstadPer NafstadKari Furu Pharmacoepidemiology and Prescription 21 November 2009 Pages: 399 - 406
Do medical students copy the drug treatment choices of their teachers or do they think for themselves? J. TichelaarM. C. RichirTh. P. G. M. De Vries Pharmacoepidemiology and Prescription Open access 24 November 2009 Pages: 407 - 412
Drug dependence associated with triptans and ergot derivatives: a case/non-case study Frédérique Beau-SalinasAnnie Pierre Jonville-BéraElisabeth Autret-Leca Pharmacoepidemiology and Prescription 19 December 2009 Pages: 413 - 417
The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study Henriette FarkasIbolya CzallerIstván Karádi Pharmacoepidemiology and Prescription 19 December 2009 Pages: 419 - 426
Possible hepatotoxic effect of rooibos tea: a case report Marjatta SinisaloAnna-Liisa EnkovaaraKari T. Kivistö Letter to the Editors 14 January 2010 Pages: 427 - 428